TCEB3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.157400E-01
Normal-vs-Stage2
2.655400E-01
Normal-vs-Stage3
3.249800E-02
Normal-vs-Stage4
3.138800E-01
Stage1-vs-Stage2
1.840440E-01
Stage1-vs-Stage3
7.205800E-02
Stage1-vs-Stage4
1.884250E-01
Stage2-vs-Stage3
1.127220E-01
Stage2-vs-Stage4
3.46990000066327E-08
Stage3-vs-Stage4
6.38689999999942E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.064600E-01
Normal-vs-AfricanAmerican
6.587200E-01
Normal-vs-Asian
7.294200E-02
Caucasian-vs-AfricanAmerican
7.135600E-01
Caucasian-vs-Asian
4.247600E-02
AfricanAmerican-vs-Asian
1.272640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.188600E-01
Normal-vs-Female
4.757800E-01
Male-vs-Female
3.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.333200E-01
Normal-vs-Age(41-60Yrs)
6.174400E-01
Normal-vs-Age(61-80Yrs)
3.356000E-01
Normal-vs-Age(81-100Yrs)
6.542400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.401600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.368000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.814400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.631700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.839600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.512010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.072000E-01
Normal-vs-Daily Drinker
2.590600E-01
Normal-vs-Weekly Drinker
3.491200E-01
Normal-vs-Occasional Drinker
9.045600E-01
Normal-vs-Social Drinker
3.274400E-01
Non Drinker-vs-Daily Drinker
2.011800E-01
Non Drinker-vs-Weekly Drinker
4.057400E-01
Non Drinker-vs-Occasional Drinker
1.079520E-02
Non Drinker-vs-Social Drinker
2.002800E-01
Daily Drinker-vs-Weekly Drinker
8.610200E-01
Daily Drinker-vs-Occasional Drinker
1.282580E-01
Daily Drinker-vs-Social Drinker
8.652400E-01
Weekly Drinker-vs-Occasional Drinker
1.847600E-01
Weekly Drinker-vs-Social Drinker
7.745200E-01
Occasional Drinker-vs-Social Drinker
2.307000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.729600E-01
Normal-vs-Grade 2
9.488200E-01
Normal-vs-Grade 3
9.743000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.163600E-01
Grade 1-vs-Grade 3
4.121600E-01
Grade 1-vs-Grade 4
7.729600E-01
Grade 2-vs-Grade 3
4.824000E-01
Grade 2-vs-Grade 4
9.488200E-01
Grade 3-vs-Grade 4
9.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.929820E-01
Normal-vs-NonDiabetic
3.374400E-01
Diabetic-vs-NonDiabetic
6.510000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.385020E-01
Normal-vs-NoPancreatitis
3.430000E-01
Pancreatitis-vs-NoPancreatitis
6.151000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.991200E-01
Normal-vs-N1
2.957200E-01
N0-vs-N1
7.987800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.605200E-01
Normal-vs-TP53-NonMutant
6.484000E-01
TP53-Mutant-vs-TP53-NonMutant
3.257000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
